The minimal informative monitoring interval of N-terminal pro-B-type natriuretic peptide in patients with stable heart failure.

In patients with stable chronic heart failure, the minimal informative monitoring interval of NT-proBNP measurement was 7.9 months in the current population, which varied with underlying risks. The optimal monitoring interval could be lengthened for patients at lower risks.